首页> 外文期刊>Medicine. >Renal artery stent in solitary functioning kidneys: 77% of benefit: A systematic review with meta-analysis
【24h】

Renal artery stent in solitary functioning kidneys: 77% of benefit: A systematic review with meta-analysis

机译:孤立性肾功能中的肾动脉支架:获益77%:荟萃分析的系统评价

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background:Solitary functioning kidney (SFK) is tough issue to address in clinical, mostly developed from renal artery stenosis (RAS) in adults. Although renal artery stent is widely used to help SFK patients, the efficacy of the stent is still disputable. This study is aimed at reviewing a series of SFK cases to draw a conclusion about the efficacy of renal artery stent.Methods:All related papers published in PubMed, Web of Science, EMBASE, and Cochrane Library were searched. Studies or subsets were included only if they satisfied certain criteria. The benefit rate which equaled the rate of improvement subjoining the rate of stabilization was calculated. All analyses were conducted with Stata version 12.0 (Stata Corporation, College Station, TX).Results:According to 7 papers on the efficacy of renal artery stent, 253 SFK patients were included. The result revealed that the renal artery stent could help SFK patients to improve or stabilize their renal function (RF). The benefit rate was 0.77, with 95% confidence interval between 0.72 and 0.83.Conclusions:With proper patient selection, renal artery stent could benefit SFK patients with a percentage odd of 0.77 to improve or stabilize the RF.
机译:背景:单功能肾(SFK)在临床上很难解决,主要是由成年人的肾动脉狭窄(RAS)引起的。尽管肾动脉支架被广泛用于帮助SFK患者,但支架的疗效仍存在争议。本研究旨在回顾一系列SFK病例,以得出有关肾动脉支架疗效的结论。仅当研究或子集满足特定条件时才包括在内。计算出的收益率等于改善率再加上稳定率。所有分析均使用Stata 12.0版(Stata Corporation,College Station,TX)进行。结果:根据7篇关于肾动脉支架疗效的论文,包括253名SFK患者。结果表明,肾动脉支架可以帮助SFK患者改善或稳定其肾功能(RF)。受益率为0.77,95%的置信区间为0.72至0.83。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号